Discover one of our 28 local entrepreneurial communities »
Be the first to know as we launch in new countries and markets around the globe.
Interested in bringing MIT Technology Review to your local market?
Unsupported browser: Your browser does not meet modern web standards. See how it scores »
Tiny Trojan horses deliver a cancer drug to cell nuclei.
Tumors can evolve resistance to powerful new cancer drugs. But scientists are now learning why, giving hints at how to stop it.
A startup is developing oxygen-carrying compounds that it says could make radiation therapy more effective in half of all cancer patients.
An experimental compound shrank lung-cancer tumors in half of the patients in a recent study.
The devices may one day help patients skip invasive and painful biopsies.
A “watershed” in sequencing technology helps physicians choose drugs for cancer patients.
Researchers inject quantum dots into the skin using plastic microneedles, potentially providing a way to diagnose and treat diseases.
Researchers call the experimental drug a major success for targeted cancer therapies.
Researchers are devising new ways to get the same results with fewer x-rays.
Drug companies are harnessing new knowledge of cancer genetics.